Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil

• Main Authors: Marjie L. Hard (Author), Angela Wehr (Author), Lisa von Moltke (Author), Yangchun Du (Author), Sarah Farwick (Author), David P. Walling (Author), John Sonnenberg (Author)
• Format: Book
• Published: SAGE Publishing, 2019-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Aripiprazole lauroxil (AL), a long-acting injectable antipsychotic for the treatment of schizophrenia in adults, can be started with either 21 days of daily oral aripiprazole supplementation or a 1-day initiation regimen consisting of a single injection of a NanoCrystal ® Dispersion form...